Clinical bottom line
Telemedicine in palliative care has demonstrated feasibility and acceptability, enhancing access to symptom management, psychosocial support, and multidisciplinary care, particularly for patients with limited mobility or geographic barriers. Evidence indicates telehealth can improve quality of life and patient satisfaction without compromising care quality. However, challenges remain regarding technology access, digital literacy, and integration into existing care pathways. Telemedicine should be considered a complementary modality to traditional palliative care, tailored to individual patient needs and contexts (Steindal et al., 2020; Guo et al., 2025).
What the evidence shows
Steindal et al. (2020) conducted a scoping review of patients’ experiences with telehealth in palliative home care, finding that patients valued increased accessibility, timely symptom management, and enhanced communication with providers. Telehealth was associated with reduced travel burden and improved feelings of safety and support.
Guo et al. (2025) provide an umbrella review summarizing digital health applications in palliative care, highlighting telemedicine’s role in symptom monitoring, advance care planning, and psychological support. They emphasize telehealth’s potential to facilitate personalized care and multidisciplinary collaboration.
Silva-Ferreira et al. (2025) map AI-based technologies in palliative care, noting that telemedicine platforms integrated with AI tools may further enhance symptom assessment and decision support, although these are in early stages.
Kotlega et al. (2025) discuss the importance of recognizing frailty and palliative needs post-stroke, advocating for telemedicine as a tool to bridge gaps in ongoing care and rehabilitation.
Nejadmasoom et al. (2024) propose the “Triple P” hypothesis—palliative care, psychological interventions, and personalized medicine—where telemedicine serves as a critical enabler to deliver integrated, patient-centered care remotely.
Caveats and uncertainty
Most studies are observational or qualitative, with limited randomized controlled trials assessing clinical outcomes.
Variability in telemedicine platforms, frequency of contact, and provider training complicates standardization.
Digital divide issues may exclude vulnerable populations lacking internet access or technological skills.
Data privacy and security concerns require ongoing attention.
Long-term impact on symptom control, hospitalizations, and survival remains to be fully elucidated.
How this may change practice
Clinicians should consider telemedicine as a valuable adjunct to in-person palliative care, especially for patients facing mobility or geographic challenges.
Incorporating telehealth requires infrastructure investment, staff training, and protocols to ensure quality and continuity.
Patient and caregiver preferences and capabilities must guide telemedicine use.
Telemedicine may facilitate earlier intervention for symptom exacerbations, potentially reducing emergency visits.
Integration with AI and remote monitoring tools could enhance personalized care and resource allocation.